Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Larynx | 1 | 2021 | 126 | 0.81 | Why? |
| Prednisolone | 1 | 2020 | 443 | 0.66 | Why? |
| Eosinophils | 2 | 2019 | 848 | 0.56 | Why? |
| Pulmonary Fibrosis | 1 | 2020 | 1068 | 0.42 | Why? |
| Sleep Apnea, Obstructive | 4 | 2019 | 668 | 0.33 | Why? |
| Phosphatidate Phosphatase | 1 | 2006 | 5 | 0.33 | Why? |
| Polyisoprenyl Phosphates | 1 | 2006 | 8 | 0.32 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.31 | Why? |
| Allergens | 2 | 2019 | 728 | 0.23 | Why? |
| Pulmonologists | 1 | 2021 | 98 | 0.21 | Why? |
| Respiratory Care Units | 1 | 2021 | 111 | 0.21 | Why? |
| Cell Count | 2 | 2017 | 228 | 0.21 | Why? |
| Receptors, Leukotriene | 1 | 2019 | 13 | 0.21 | Why? |
| Dermatophagoides farinae | 1 | 2019 | 1 | 0.20 | Why? |
| Still's Disease, Adult-Onset | 1 | 2021 | 100 | 0.20 | Why? |
| Flour | 1 | 2019 | 17 | 0.20 | Why? |
| Immunoglobulin E | 3 | 2017 | 557 | 0.20 | Why? |
| Sleep Stages | 1 | 2019 | 52 | 0.19 | Why? |
| Asthma | 4 | 2019 | 4383 | 0.19 | Why? |
| Signal Recognition Particle | 1 | 2018 | 39 | 0.19 | Why? |
| Sleep Apnea, Central | 1 | 2018 | 28 | 0.18 | Why? |
| Dermatomyositis | 1 | 2021 | 193 | 0.18 | Why? |
| Schizophyllum | 1 | 2017 | 4 | 0.18 | Why? |
| Lung | 5 | 2021 | 31049 | 0.18 | Why? |
| Histidine | 1 | 2017 | 72 | 0.17 | Why? |
| Thioctic Acid | 1 | 2017 | 27 | 0.17 | Why? |
| Aspergillosis, Allergic Bronchopulmonary | 1 | 2017 | 38 | 0.17 | Why? |
| Pulmonary Emphysema | 1 | 2018 | 122 | 0.17 | Why? |
| Antigens, Fungal | 1 | 2017 | 106 | 0.16 | Why? |
| Hypersensitivity, Immediate | 1 | 2017 | 134 | 0.15 | Why? |
| Tobacco Smoke Pollution | 1 | 2018 | 181 | 0.15 | Why? |
| Sleep Apnea Syndromes | 1 | 2018 | 282 | 0.14 | Why? |
| Diagnostic Self Evaluation | 1 | 2019 | 394 | 0.14 | Why? |
| Antiphospholipid Syndrome | 1 | 2020 | 533 | 0.13 | Why? |
| Aspergillus | 1 | 2017 | 347 | 0.13 | Why? |
| Atrial Fibrillation | 2 | 2018 | 2320 | 0.13 | Why? |
| Th2 Cells | 1 | 2017 | 680 | 0.13 | Why? |
| Japan | 7 | 2021 | 6653 | 0.13 | Why? |
| Catheter Ablation | 1 | 2018 | 438 | 0.13 | Why? |
| Alveolar Epithelial Cells | 1 | 2021 | 1445 | 0.12 | Why? |
| Polysomnography | 3 | 2019 | 296 | 0.12 | Why? |
| Bronchiectasis | 1 | 2017 | 312 | 0.12 | Why? |
| Muscular Diseases | 1 | 2018 | 392 | 0.12 | Why? |
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2020 | 645 | 0.11 | Why? |
| Rhinitis | 1 | 2019 | 626 | 0.11 | Why? |
| Leukocyte Count | 2 | 2019 | 3178 | 0.11 | Why? |
| Sinusitis | 1 | 2019 | 649 | 0.11 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.11 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.11 | Why? |
| Proteinase Inhibitory Proteins, Secretory | 1 | 2010 | 43 | 0.10 | Why? |
| Molecular Targeted Therapy | 1 | 2019 | 1579 | 0.10 | Why? |
| Continuous Positive Airway Pressure | 1 | 2019 | 1187 | 0.10 | Why? |
| Glycated Hemoglobin A | 1 | 2017 | 1316 | 0.10 | Why? |
| Anaphylaxis | 1 | 2019 | 940 | 0.10 | Why? |
| Drug Evaluation, Preclinical | 1 | 2021 | 3347 | 0.10 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2020 | 1380 | 0.09 | Why? |
| Glycine | 1 | 2010 | 203 | 0.09 | Why? |
| Taste Disorders | 1 | 2020 | 1720 | 0.09 | Why? |
| Acute Lung Injury | 1 | 2017 | 904 | 0.09 | Why? |
| Anti-Inflammatory Agents | 2 | 2018 | 6153 | 0.09 | Why? |
| Lung Diseases, Interstitial | 1 | 2018 | 1476 | 0.08 | Why? |
| Gastric Acid | 1 | 2006 | 25 | 0.08 | Why? |
| Hyperglycemia | 1 | 2017 | 1363 | 0.08 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.08 | Why? |
| Lipoxins | 1 | 2006 | 64 | 0.08 | Why? |
| Smoking | 1 | 2018 | 3358 | 0.07 | Why? |
| Enzyme Activation | 1 | 2006 | 425 | 0.07 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 11367 | 0.07 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.07 | Why? |
| Sulfonamides | 2 | 2010 | 1294 | 0.07 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.06 | Why? |
| Humans | 29 | 2021 | 930598 | 0.06 | Why? |
| Neutrophil Activation | 1 | 2006 | 510 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.06 | Why? |
| Inflammation | 3 | 2018 | 13255 | 0.06 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.05 | Why? |
| Lipid Metabolism | 1 | 2006 | 572 | 0.05 | Why? |
| Spheroids, Cellular | 1 | 2021 | 124 | 0.05 | Why? |
| Wnt Signaling Pathway | 1 | 2021 | 87 | 0.05 | Why? |
| Rats, Sprague-Dawley | 2 | 2017 | 987 | 0.05 | Why? |
| Pulmonary Diffusing Capacity | 1 | 2021 | 191 | 0.05 | Why? |
| Nitric Oxide | 2 | 2017 | 769 | 0.05 | Why? |
| Molecular Sequence Data | 1 | 2006 | 3198 | 0.05 | Why? |
| Reactive Oxygen Species | 1 | 2006 | 1136 | 0.05 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Interferon-Induced Helicase, IFIH1 | 1 | 2021 | 245 | 0.05 | Why? |
| Bronchi | 1 | 2006 | 1048 | 0.05 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.05 | Why? |
| Male | 14 | 2021 | 367725 | 0.05 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 372 | 0.05 | Why? |
| Diet, Diabetic | 1 | 2017 | 7 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Respiratory Mucosa | 1 | 2006 | 1522 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
| Biomarkers, Pharmacological | 1 | 2017 | 150 | 0.04 | Why? |
| Female | 11 | 2021 | 380317 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.04 | Why? |
| Forced Expiratory Volume | 1 | 2017 | 632 | 0.03 | Why? |
| Cell Adhesion Molecules | 1 | 2017 | 472 | 0.03 | Why? |
| Microscopy | 1 | 2017 | 414 | 0.03 | Why? |
| Cells, Cultured | 2 | 2021 | 5835 | 0.03 | Why? |
| Amino Acid Sequence | 1 | 2006 | 6049 | 0.03 | Why? |
| Eosinophilia | 1 | 2017 | 292 | 0.03 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.03 | Why? |
| Fungi | 1 | 2017 | 471 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2021 | 1755 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Epithelial Cells | 1 | 2006 | 3508 | 0.03 | Why? |
| Monitoring, Ambulatory | 1 | 2017 | 343 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.03 | Why? |
| Sepsis | 1 | 2010 | 3517 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Healthy Lifestyle | 1 | 2017 | 447 | 0.03 | Why? |
| Hypoglycemia | 1 | 2017 | 406 | 0.03 | Why? |
| Aged | 8 | 2021 | 215776 | 0.03 | Why? |
| Adenocarcinoma | 1 | 2018 | 651 | 0.03 | Why? |
| Overweight | 1 | 2017 | 916 | 0.03 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2017 | 665 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Cytokines | 3 | 2017 | 15010 | 0.03 | Why? |
| Workload | 1 | 2021 | 1887 | 0.03 | Why? |
| Cecum | 1 | 2010 | 63 | 0.03 | Why? |
| Ligation | 1 | 2010 | 84 | 0.03 | Why? |
| Cross-Sectional Studies | 4 | 2019 | 53120 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.02 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.02 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.02 | Why? |
| Heart Rate | 1 | 2019 | 1527 | 0.02 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.02 | Why? |
| Antigens, Differentiation, Myelomonocytic | 1 | 2010 | 198 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| HMGB1 Protein | 1 | 2010 | 223 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Immunity, Innate | 1 | 2006 | 6570 | 0.02 | Why? |
| Single-Cell Analysis | 1 | 2017 | 2450 | 0.02 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.02 | Why? |
| Receptors, Lipoxin | 1 | 2006 | 2 | 0.02 | Why? |
| Nitrobenzenes | 1 | 2006 | 12 | 0.02 | Why? |
| Hydrochloric Acid | 1 | 2006 | 21 | 0.02 | Why? |
| Animals | 4 | 2019 | 78931 | 0.02 | Why? |
| Receptors, Formyl Peptide | 1 | 2006 | 26 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Disease Models, Animal | 2 | 2018 | 10998 | 0.02 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.02 | Why? |
| Cyclooxygenase 2 | 1 | 2006 | 129 | 0.02 | Why? |
| Immunoglobulins, Intravenous | 1 | 2018 | 2705 | 0.02 | Why? |
| Dinoprostone | 1 | 2006 | 101 | 0.02 | Why? |
| Cell Adhesion | 1 | 2006 | 230 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Antigens, CD | 1 | 2010 | 984 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Interleukin-8 | 1 | 2010 | 964 | 0.02 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.02 | Why? |
| Microscopy, Electron, Transmission | 1 | 2006 | 605 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Rats | 1 | 2010 | 2764 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Cell Proliferation | 1 | 2006 | 1973 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Survival Analysis | 1 | 2010 | 7592 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Membrane Proteins | 1 | 2006 | 1733 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
Fukunaga's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(196)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(152)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_